PL3071230T3 - Kompozycje do leczenia reumatoidalnego zapalenia stawów oraz sposoby ich stosowania - Google Patents

Kompozycje do leczenia reumatoidalnego zapalenia stawów oraz sposoby ich stosowania

Info

Publication number: PL3071230T3
Authority: PL; Poland
Prior art keywords: compositions; treatment; methods; same; rheumatoid arthritis
Prior art date: 2013-11-22

Application number

PL14812084T

Other languages

English (en)

Inventor

Xiaohong Huang

Martine JASSON

Vanessa MARKS

Allen Radin

Chungpeng FAN

Hubert VAN HOOGSTRATEN

Stefano FIORE

Janet VAN ADELSBERG

Mark Genovese

Original Assignee

Sanofi Biotechnology

Regeneron Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-11-22

Filing date

2014-11-21

Publication date

2020-09-21

2014-11-21 Application filed by Sanofi Biotechnology, Regeneron Pharmaceuticals, Inc. filed Critical Sanofi Biotechnology

2020-09-21 Publication of PL3071230T3 publication Critical patent/PL3071230T3/pl

Links

239000000203 mixture Substances 0.000 title 1
206010039073 rheumatoid arthritis Diseases 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/248—IL-6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Mycology (AREA)
Endocrinology (AREA)
Microbiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL14812084T 2013-11-22 2014-11-21 Kompozycje do leczenia reumatoidalnego zapalenia stawów oraz sposoby ich stosowania PL3071230T3 (pl)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US201361907796P	2013-11-22	2013-11-22
US201462008787P	2014-06-06	2014-06-06
EP14306366		2014-09-05
PCT/US2014/066856 WO2015077582A1 (en)	2013-11-22	2014-11-21	Compositions for the treatment of rheumatoid arthritis and methods of using same
EP14812084.3A EP3071230B1 (en)	2013-11-22	2014-11-21	Compositions for the treatment of rheumatoid arthritis and methods of using same

Publications (1)

Publication Number	Publication Date
PL3071230T3 true PL3071230T3 (pl)	2020-09-21

Family

ID=51518724

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL14812084T PL3071230T3 (pl)	2013-11-22	2014-11-21	Kompozycje do leczenia reumatoidalnego zapalenia stawów oraz sposoby ich stosowania

Country Status (11)

Country	Link
US (1)	US20160280782A1 (pl)
EP (2)	EP3770173A1 (pl)
JP (3)	JP6657089B2 (pl)
KR (3)	KR20220056254A (pl)
CN (1)	CN106413748A (pl)
AU (3)	AU2014352801B2 (pl)
CA (1)	CA2930615C (pl)
MX (2)	MX2016006595A (pl)
PL (1)	PL3071230T3 (pl)
SG (1)	SG10201804000TA (pl)
WO (1)	WO2015077582A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JO3417B1 (ar)	2010-01-08	2019-10-20	Regeneron Pharma	الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
US9943594B2 (en)	2011-10-11	2018-04-17	Sanofi Biotechnology	Methods for the treatment of rheumatoid arthritis
TWI589299B (zh)	2011-10-11	2017-07-01	再生元醫藥公司	用於治療類風濕性關節炎之組成物及其使用方法
AU2016348418B8 (en)	2015-11-03	2023-10-19	Regeneron Pharmaceuticals, Inc.	Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using same
EP3216461A1 (en) *	2016-03-07	2017-09-13	Sanofi Biotechnology	Compositions and methods for treating rheumatoid arthritis
SG11201807614SA (en) *	2016-03-07	2018-10-30	Sanofi Biotechnology	Compositions and methods for treating rheumatoid arthritis
KR102618377B1 (ko)	2017-12-07	2023-12-27	후지모리 고교 가부시키가이샤	포트가 부착된 백 및 캡이 부착된 백
AU2019329958A1 (en) *	2018-08-29	2021-03-18	Regeneron Pharmaceuticals, Inc.	Methods and compositions for treating subjects having rheumatoid arthritis
CA3128212A1 (en)	2019-01-31	2020-08-06	Sanofi Biotechnology	Anti-il-6 receptor antibody for treating juvenile idiopathic arthritis
US20200405851A1 (en) *	2019-04-24	2020-12-31	Sanofi Biotechnology	Method of diagnosis and treatment of rheumatoid arthritis
JP7373958B2 (ja)	2019-09-27	2023-11-06	株式会社日立製作所	分析システム及び分析方法
KR20210040735A (ko)	2019-10-05	2021-04-14	양수현	천장 수납형 빨래 건조대

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6659982B2 (en)	2000-05-08	2003-12-09	Sterling Medivations, Inc.	Micro infusion drug delivery device
US6629949B1 (en)	2000-05-08	2003-10-07	Sterling Medivations, Inc.	Micro infusion drug delivery device
US8080248B2 (en) *	2006-06-02	2011-12-20	Regeneron Pharmaceuticals, Inc.	Method of treating rheumatoid arthritis with an IL-6R antibody
TWI589299B (zh) *	2011-10-11	2017-07-01	再生元醫藥公司	用於治療類風濕性關節炎之組成物及其使用方法
ES2799439T3 (es) *	2013-11-22	2020-12-17	Sanofi Biotechnology	Composiciones para el tratamiento de la artritis reumatoide y métodos de uso de las mismas

2014
- 2014-11-21 KR KR1020227013977A patent/KR20220056254A/ko not_active IP Right Cessation
- 2014-11-21 EP EP20167644.2A patent/EP3770173A1/en active Pending
- 2014-11-21 US US15/034,531 patent/US20160280782A1/en active Pending
- 2014-11-21 JP JP2016533206A patent/JP6657089B2/ja active Active
- 2014-11-21 CA CA2930615A patent/CA2930615C/en active Active
- 2014-11-21 SG SG10201804000TA patent/SG10201804000TA/en unknown
- 2014-11-21 MX MX2016006595A patent/MX2016006595A/es active IP Right Grant
- 2014-11-21 KR KR1020167016059A patent/KR20160079121A/ko active Application Filing
- 2014-11-21 CN CN201480073774.5A patent/CN106413748A/zh active Pending
- 2014-11-21 AU AU2014352801A patent/AU2014352801B2/en active Active
- 2014-11-21 WO PCT/US2014/066856 patent/WO2015077582A1/en active Application Filing
- 2014-11-21 EP EP14812084.3A patent/EP3071230B1/en active Active
- 2014-11-21 PL PL14812084T patent/PL3071230T3/pl unknown
- 2014-11-21 KR KR1020237036134A patent/KR20230155586A/ko not_active Application Discontinuation
2016
- 2016-05-20 MX MX2020011993A patent/MX2020011993A/es unknown
2020
- 2020-08-26 AU AU2020223706A patent/AU2020223706B2/en active Active
2021
- 2021-12-03 JP JP2021196599A patent/JP2022033891A/ja active Pending
2023
- 2023-11-30 JP JP2023202342A patent/JP2024026223A/ja active Pending
2024
- 2024-07-16 AU AU2024204881A patent/AU2024204881A1/en active Pending

Also Published As

Publication number	Publication date
JP2022033891A (ja)	2022-03-02
AU2024204881A1 (en)	2024-08-15
CA2930615C (en)	2023-04-04
US20160280782A1 (en)	2016-09-29
KR20160079121A (ko)	2016-07-05
JP2024026223A (ja)	2024-02-28
AU2020223706A1 (en)	2020-09-10
MX2016006595A (es)	2016-09-06
SG10201804000TA (en)	2018-07-30
EP3071230A1 (en)	2016-09-28
AU2020223706B2 (en)	2024-04-18
JP6657089B2 (ja)	2020-03-04
KR20220056254A (ko)	2022-05-04
JP2016539125A (ja)	2016-12-15
CN106413748A (zh)	2017-02-15
EP3071230B1 (en)	2020-04-08
AU2014352801A1 (en)	2016-06-23
CA2930615A1 (en)	2015-05-28
WO2015077582A1 (en)	2015-05-28
AU2014352801B2 (en)	2020-05-28
MX2020011993A (es)	2021-01-29
EP3770173A1 (en)	2021-01-27
KR20230155586A (ko)	2023-11-10

Publication	Publication Date	Title
HRP20192145T1 (hr)	2020-05-15	Pripravci nosača-antitijela i metode pripreme i uporabe istih
HK1225654A1 (zh)	2017-09-15	用於治療老花眼的組合物及方法
IL232001A0 (en)	2014-05-28	Preparations for the treatment of rheumatoid arthritis and methods of using them
IL265876A (en)	2019-06-30	Preparations that include 15-ohepa and methods of using them
PL3071230T3 (pl)	2020-09-21	Kompozycje do leczenia reumatoidalnego zapalenia stawów oraz sposoby ich stosowania
HK1214171A1 (zh)	2016-07-22	賽尼克韋羅組合物及其製備和使用方法
EP3008170A4 (en)	2016-11-09	SC-CELLS AND COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
HK1220374A1 (zh)	2017-05-05	用於治療碳氧血紅蛋白血症的組合物和方法
PT3113774T (pt)	2022-02-28	Composições de grapiprant e métodos de utilização das mesmas
EP3068431A4 (en)	2017-08-23	Methods and compositions for the treatment of hcmv
EP3294339A4 (en)	2019-02-20	METHODS AND COMPOSITIONS FOR THE TREATMENT OF ARTHRITIS
IL239812A0 (en)	2015-08-31	Method and composition for the treatment of arthritis and osteoarthritis
HK1225635A1 (zh)	2017-09-15	用於類風濕性關節炎治療的組合物及使用該組合物的方法
IL286709A (en)	2021-10-31	Compositions for the treatment of rheumatoid arthritis and methods of using same
GB201300628D0 (en)	2013-02-27	Compositions comprising 15-OHEPA and methods of using the same